Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis

Frontiers in Medicine

Rahul Kashyap¹  Vikas Bansal¹  Aysun Tekin¹  Mack Sheraton²  Abhishek Bhurwal³  Shivam Gulati⁴  Ishita Gupta⁵  Sawai Singh Rathore⁶  Sohiel Deshpande⁷  Romil Singh⁸  Ishita Mehra⁹  Hira Khan^1,10  Paige Armaly^1,11  Kiran S. Mahapure^1,12 

[1] Department of Anaesthesiology and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States;Department of Emergency Medicine, Trinity West Medical Center MSOPTI EM Program, Steubenville, OH, United States;Department of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, NJ, United States;Department of Internal Medicine, Adesh Institute of Medical Sciences and Research, Bathinda, India;Department of Internal Medicine, Dr. Rajendra Prasad Government Medical College, Tanda, India;Department of Internal Medicine, Dr. Sampurnanand Medical College, Jodhpur, India;Department of Internal Medicine, Maharashtra Institute of Medical Education and Research, Pune, India;Department of Internal Medicine, Metropolitan Hospital, Jaipur, India;Department of Internal Medicine, North Alabama Medical Center, Florence, AL, United States;Department of Internal Medicine, Riphah International University Islamic International Medical College, Rawalpindi, Pakistan;Department of Internal Medicine, University of the West Indies, Nassau, Bahamas;Senior Resident, Department of Plastic Surgery, KAHER J. N. Medical College, Belgaum, India;

关键词: COVID-19;    SARS-CoV 2;    mortality;    plasma therapy;    systemic review and meta-analysis;    convalescent plasma;   

DOI  :  10.3389/fmed.2021.624924

来源: Frontiers

【 授权许可】

CC BY